Target intelligence / Profile preview

Cytochrome b-245 heavy chain mRNA (NOX2 mRNA) (NOX2 mRNA)

Target
NOX2 mRNA
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Cytochrome b-245 heavy chain mRNA, commonly known as NOX2 mRNA, is the transcript of the CYBB gene located on the X chromosome (NCBI Gene ID: 1536). It encodes the gp91-phox protein, which serves as the catalytic core of the NADPH oxidase 2 complex, an enzyme primarily expressed in phagocytes that generates superoxide anions during the respiratory burst (UniProt: P04839). This process is essential for the innate immune system's ability to destroy invading pathogens. However, the dysregulation or overexpression of NOX2 mRNA is heavily implicated in the pathogenesis of various diseases characterized by oxidative stress, including atherosclerosis, hypertension, and neurodegenerative disorders like Alzheimer's disease (PubMed: 25223554). Therapeutic strategies targeting NOX2 mRNA, such as small interfering RNAs (siRNA) and antisense oligonucleotides (ASOs), are being investigated to selectively downregulate NOX2 expression and mitigate tissue damage caused by excessive reactive oxygen species (PubMed: 21653890). A significant challenge in targeting this molecule is the risk of inducing an immunocompromised state similar to Chronic Granulomatous Disease, which results from a total loss of NOX2 function (StatPearls: NBK537072).

Other names
CYBB mRNAgp91-phox mRNANADPH oxidase 2 mRNAp91-PHOX mRNACytochrome b-245 beta polypeptide mRNA
02

Mechanism of action

RNA interference or antisense-mediated degradation of mRNA to inhibit translation of the NOX2 protein, thereby reducing superoxide production.

03

Biological functions

Protein synthesisReactive oxygen species productionImmune responsePhagocytosisCell signaling
04

Disease associations

InflammationCardiovascular diseaseNeurodegenerative diseaseStrokeChronic Granulomatous DiseaseCancer
05

Safety considerations

Increased susceptibility to bacterial and fungal infectionsOff-target effects of RNA-targeting moleculesDelivery vehicle toxicityPotential for Chronic Granulomatous Disease-like phenotype if over-suppressed
06

Interacting drugs

NOX2-siRNA

1 more in the full profile.

07

Biomarkers

NOX2 mRNA expression levelsSuperoxide productionReactive oxygen species (ROS) levelsgp91-phox protein levels

Beyond the preview

Go deeper on Cytochrome b-245 heavy chain mRNA (NOX2 mRNA) (NOX2 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome b-245 heavy chain mRNA (NOX2 mRNA) (NOX2 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call